MECHANISM OF METABOLIC CLEAVAGE OF A FURAN RING
- 1 November 1987
- journal article
- research article
- Vol. 15 (6) , 877-881
Abstract
We studied the mechanism of metabolism cleavage of a furan ring, using a new hypolipidemic agent, ethyl 2-(4-chlorophenyl)-5-(2-furyl)oxazole-4-acetate (TA-1801), as a model compound. A TA-1801 analogue labeled with deuterium at the 5-position of its furan ring was administered orally to rats. The analysis of urinary metabolites by GC/MS revealed that the deuterium of the furan was retained in the ring-opened metabolite (M3). Metabolic cleavage of furan has been generally considered to proceed by hydroxylation of the 5-position followed by tautomerism and hydrolysis of the resulting 5-hydroxyfuran derivative. However, if the cleavage proceeded by this pathway, the deuterium of the 5-position would be eliminated during hydroxylation. Therefore, we propose that the ring was cleaved directly to form an unsaturated aldehyde, considering the mechanism of oxidation by cytochrome P-450. Although this "intermediate" was not detected in the biological specimens, a synthetic unsaturated aldehyde was transformed to the actual urinary metabolites M2 and M3 (major ring-opened metabolites) in the isolated rat liver.This publication has 4 references indexed in Scilit:
- METABOLISM OF ETHYL 2-(4-CHLOROPHENYL)-5-(2-FURYL)-OXAZOLE-4-ACETATE, A NEW HYPOLIPIDEMIC AGENT, IN THE RAT, RABBIT, AND DOG - GLUCURONIDATION OF CARBOXYL GROUP AND CLEAVAGE OF FURAN RING1987
- Reactive Metabolites From the Bioactivation of Toxic MethylfuransScience, 1984
- Isolation and identification of urinary metabolites of AF-2 (3-(5-nitro-2-furyl)-2-(2-furyl)acrylamide) in rabbitsBiochemical and Biophysical Research Communications, 1977
- Absorption, Distribution, Metabolism, and Excretion of Furosemide in Dogs and Monkeys I: Analytical Methodology, Metabolism, and Urinary ExcretionJournal of Pharmaceutical Sciences, 1976